ANTX logo

ANTXAN2 Therapeutics Inc

$4.20
$0.29
(7.42%)
Today
Closed $4.20
$0.00
(0.00%)
After Hours
Updated: 07:02 PM EDT
Reported EarningsMay 11
Mkt Cap$140.82M
Vol188,511.00

About

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley in 2017 and is headquartered in Menlo Park, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
21

Frequently Asked Questions

What is Market Cap of AN2 Therapeutics Inc?
What is the 52-week high for AN2 Therapeutics Inc?
What is the 52-week low for AN2 Therapeutics Inc?
What is AN2 Therapeutics Inc stock price today?
What was AN2 Therapeutics Inc stock price yesterday?
What is the PE ratio of AN2 Therapeutics Inc?
What is the Price-to-Book ratio of AN2 Therapeutics Inc?
What is the 50-day moving average of AN2 Therapeutics Inc?
How many employees does AN2 Therapeutics Inc have?

Advertisement|Remove ads.